Humana (NYSE:HUM) Trading Down 4.7%

Humana Inc. (NYSE:HUM)’s stock price was down 4.7% during trading on Wednesday . The company traded as low as $311.58 and last traded at $312.63. Approximately 1,250,091 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 1,976,503 shares. The stock had previously closed at $327.98.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on HUM shares. Truist Financial reissued a “hold” rating and issued a $550.00 price target on shares of Humana in a research report on Friday, January 19th. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Raymond James began coverage on shares of Humana in a research report on Friday, March 22nd. They set a “market perform” rating on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating and dropped their target price for the stock from $595.00 to $360.00 in a research report on Thursday, January 25th. Finally, UBS Group reaffirmed a “neutral” rating and set a $370.00 target price (down previously from $530.00) on shares of Humana in a research report on Friday, January 26th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $454.63.

Humana Trading Down 3.7 %

The company’s fifty day moving average price is $329.86 and its two-hundred day moving average price is $398.38. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm has a market cap of $38.12 billion, a P/E ratio of 15.64, a price-to-earnings-growth ratio of 1.91 and a beta of 0.45.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the prior year, the firm earned $9.38 EPS. The company’s revenue was up 10.7% on a year-over-year basis. As a group, sell-side analysts predict that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.12%. Humana’s payout ratio is presently 17.86%.

Insider Activity at Humana

In other news, Director Jorge S. Mesquita purchased 545 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the transaction, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.29% of the stock is currently owned by corporate insiders.

Institutional Trading of Humana

Several hedge funds have recently bought and sold shares of HUM. Rakuten Securities Inc. bought a new position in shares of Humana during the 4th quarter worth approximately $25,000. Gradient Investments LLC increased its position in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares during the period. Cetera Trust Company N.A bought a new position in Humana during the fourth quarter worth about $28,000. Private Wealth Management Group LLC bought a new position in Humana in the 4th quarter valued at about $32,000. Finally, Nvwm LLC increased its holdings in Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.